Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Visum Light has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Light Therapy Device Companies - 2023,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Sharon Katzke, CEO and President.
Sharon Katzke, CEO and PresidentThe Visum Light device has evolved beyond its traditional role in healing after injuries and can now be incorporated into one’s wellness regimen, much like a reliable supplement. It acts preventatively, operating at the cellular level to help maintain a robust immune system, enabling the body to better defend against external threats and illnesses.![]()
Our device integrates different light and sound wavelengths into one convenient, battery-operated device to relieve pain and promote healing
Company
Visum Light
Management
Sharon Katzke, CEO and President
Description
Visum Light enables access to comprehensive light therapy through its handheld LED light devices. Unlike one-size-fits-all devices, the Visum Light offers diverse color spectrums and sound frequencies along with seamless user customization, delivering pain relief and enhancing well-being.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
